Trans and CIS traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity
申请人:LIFEGROUP S.p.A.
公开号:EP0599188A1
公开(公告)日:1994-06-01
Traumatic acid salts, wherein B is a pharmaceutically active cation selected from :
a) a quaternary ammonium,
b) a cation of a linear or branched C₁-C₂₀ mono-, di- or tri-alkanolamine,
c) a cation of a biologically active primary, secondary or tertiary amine,
d) silver or zinc cation,
and relative pharmaceutical compositions administrable by topical or parenteral route for the therapeutic treatment of cutaneous pathologies in which it is important to associate an a bacteriostatic, antibiotic, antifungal or an antiviral activity, to the cicatrizant effect, typical of traumatic acid.
创伤酸盐,其中 B 是选自以下物质的具有药学活性的阳离子:
a) 季铵、
b) 直链或支链 C₁-C₂₀单烷醇胺、二烷醇胺或三烷醇胺的阳离子、
c) 具有生物活性的伯胺、仲胺或叔胺的阳离子、
d) 银或锌阳离子、
以及可通过局部或非肠道给药途径用于皮肤病治疗的相关药物组合物,在皮肤病治疗中,将创伤酸典型的抗菌、抗生素、抗真菌或抗病毒活性与创口止痒效果结合起来非常重要。